PL366101A1 - Kompozycja żelowa i przezmosznowe podawanie kompozycji do leczenia niedoczynności gonad (hipogonadyzmu) - Google Patents

Kompozycja żelowa i przezmosznowe podawanie kompozycji do leczenia niedoczynności gonad (hipogonadyzmu)

Info

Publication number
PL366101A1
PL366101A1 PL01366101A PL36610101A PL366101A1 PL 366101 A1 PL366101 A1 PL 366101A1 PL 01366101 A PL01366101 A PL 01366101A PL 36610101 A PL36610101 A PL 36610101A PL 366101 A1 PL366101 A1 PL 366101A1
Authority
PL
Poland
Prior art keywords
composition
hypogonadism
treatment
trans
gel composition
Prior art date
Application number
PL01366101A
Other languages
English (en)
Other versions
PL206702B1 (pl
Inventor
Bernd Schulze
Eberhard Nieschlag
Original Assignee
Dr.August Wolff Gmbh & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr.August Wolff Gmbh & Co. filed Critical Dr.August Wolff Gmbh & Co.
Publication of PL366101A1 publication Critical patent/PL366101A1/pl
Publication of PL206702B1 publication Critical patent/PL206702B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL366101A 2000-12-22 2001-12-20 Zastosowanie kompozycji żelowej do leczenia hipogonadyzmu PL206702B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064205 2000-12-22
PCT/EP2001/015123 WO2002051421A2 (de) 2000-12-22 2001-12-20 Gelzusammensetzung und transskrotale applikation einer zusammensetzung zur behandlung von hypogonadismus

Publications (2)

Publication Number Publication Date
PL366101A1 true PL366101A1 (pl) 2005-01-24
PL206702B1 PL206702B1 (pl) 2010-09-30

Family

ID=7668398

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366101A PL206702B1 (pl) 2000-12-22 2001-12-20 Zastosowanie kompozycji żelowej do leczenia hipogonadyzmu

Country Status (17)

Country Link
US (2) US20040044086A1 (pl)
EP (1) EP1347764B1 (pl)
AT (1) ATE356626T1 (pl)
CA (1) CA2432534C (pl)
CY (1) CY1106595T1 (pl)
CZ (1) CZ20031761A3 (pl)
DE (2) DE50112206D1 (pl)
DK (1) DK1347764T3 (pl)
EE (1) EE05318B1 (pl)
ES (1) ES2283446T3 (pl)
HR (1) HRP20030510A2 (pl)
HU (1) HUP0600234A3 (pl)
PL (1) PL206702B1 (pl)
PT (1) PT1347764E (pl)
SI (1) SI1347764T1 (pl)
SK (1) SK7932003A3 (pl)
WO (1) WO2002051421A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
JP2008512425A (ja) * 2004-09-09 2008-04-24 ラボラトワール ブザン アンテルナスィヨナル 透過促進剤としてのプロピレングリコールを含むテストステロンゲル
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860712A (en) * 1973-04-16 1975-01-14 Sterling Drug Inc Composition and method for treatment of acne or seborrhea
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
DK3994A (da) * 1994-01-10 1995-07-11 Frank Nielsen CDopbevaringssystem hvor CDcoverne monteres på en skinne
WO1997041865A1 (de) * 1996-05-02 1997-11-13 Azupharma Gmbh Topische penile androgen-applikation zur behandlung der erektilen dysfunktion
EP0954260A1 (en) * 1996-05-22 1999-11-10 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
JP4139860B2 (ja) * 1997-11-10 2008-08-27 ストラカン インターナショナル リミティッド 浸透増強および刺激減少システム
DE19803193C1 (de) * 1998-01-28 1999-07-15 August Wolff Gmbh & Co Arzneim Pharmazeutische Zusammensetzung mit Lecithin und alpha-Bisabolol als Penetrationsbeschleuniger
ATE485837T1 (de) * 2000-08-03 2010-11-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
PT1317921E (pt) * 2001-12-07 2009-11-06 Besins Mfg Belgium Composição farmacêutica sob a forma de gel ou de solução à base de di-hidrotestosterona, seu processo de preparação e suas utilizações

Also Published As

Publication number Publication date
CA2432534A1 (en) 2002-07-04
US20040044086A1 (en) 2004-03-04
ATE356626T1 (de) 2007-04-15
HUP0600234A2 (en) 2006-07-28
DK1347764T3 (da) 2007-07-23
SI1347764T1 (sl) 2007-06-30
DE20121209U1 (de) 2002-06-20
CA2432534C (en) 2009-09-22
HUP0600234A3 (en) 2011-04-28
PL206702B1 (pl) 2010-09-30
EP1347764A2 (de) 2003-10-01
ES2283446T3 (es) 2007-11-01
PT1347764E (pt) 2007-06-01
EE05318B1 (et) 2010-08-16
SK7932003A3 (en) 2003-11-04
EE200300305A (et) 2003-12-15
CZ20031761A3 (cs) 2004-01-14
CY1106595T1 (el) 2012-01-25
DE50112206D1 (de) 2007-04-26
US20100317631A1 (en) 2010-12-16
WO2002051421A3 (de) 2002-11-07
HRP20030510A2 (en) 2005-04-30
EP1347764B1 (de) 2007-03-14
WO2002051421A2 (de) 2002-07-04

Similar Documents

Publication Publication Date Title
PL366101A1 (pl) Kompozycja żelowa i przezmosznowe podawanie kompozycji do leczenia niedoczynności gonad (hipogonadyzmu)
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
DK0748190T3 (da) Progestogenfrie formuleringer af GnRH og estrogen til behandling af benigne gynækologiske lidelser
BG106030A (en) Pharmaceutical composition
YU68002A (sh) Modifikovani faktor viii
MY127247A (en) New pharmaceutical composition
PT746327E (pt) Nitrito acidificado como um agente antimicrobiano
AU2386201A (en) Substituted sapogenins and their use
WO2001017543A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
BRPI0209619B8 (pt) agente promotor de crescimento capilar
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
GB9714274D0 (en) Pharmaceutical composition
UA29473C2 (uk) Фунгіцидна композиція, спосіб боротьби з фітопатогенними грибами
ES2166549T3 (es) Procedimiento de preparacion de 17-esteres de 9alfa,21-dihalo-pregnan-11beta,17alfadiol-20-onas.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
AU4162402A (en) Process
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
AP1691A (en) A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines.
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
ATE212231T1 (de) Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie
PL1635843T3 (pl) Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest
ATE514426T1 (de) Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure
UA32303A (uk) Спосіб лікування папіломатозу
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20101220